COM:AGIOS
Agios Pharmaceuticals, Inc.
- Stock
Company Information
msh id | COM:AGIOS |
symbol | AGIO |
name | Agios Pharmaceuticals, Inc. |
homepage url | https://www.agios.com |
country | US |
sector | Healthcare |
industry | Biotechnology |
market | STOCKS |
employee count | 383 |
crunchbase url | - |
linkedin url | - |
founders | - |
Market Metrics
market cap | 2.47B |
enterprise value | - |
stage | - |
raised capital | - |
valuation | - |
Web & Growth Metrics
monthly webtraffic | - |
monthly webtraffic growth | - |
growth score 14 | - |
growth score 28 | - |
growth score 90 | - |
growth score 365 | - |
LTM & NTM Metrics
revenue ltm | - |
gross profit ltm | - |
ebitda ltm | - |
net income ltm | - |
revenue ntm | - |
gross profit ntm | - |
ebitda ntm | - |
net income ntm | - |
Growth & Performance Metrics
growth cost and expenses | 0.04 |
growth cost of revenue | 4.58 |
growth depreciation and amortization | 1.05 |
growth ebitda | 0.27 |
growth ebitda ratio | 0.61 |
growth eps | - |
growth eps diluted | - |
growth general and administrative expenses | - |
growth gross profit | 0.38 |
growth gross profit ratio | -0.27 |
Operating Metrics
cost and expenses | 418.31M |
cost of revenue | 418.31M |
depreciation and amortization | 6.62M |
ebitda | -384.86M |
ebitda ratio | -14.35 |
eps | -6.33 |
eps diluted | -6.33 |
operating expenses | 408.81M |
operating income | -391.49M |
operating income ratio | -14.6 |
Balance Sheet Metrics
accounts receivables | -604K |
capital expenditure | -999K |
cash at beginning of period | 139.26M |
cash at end of period | 88.21M |
inventory | 19.08M |
working capital ttm | 702.1M |
Financial Metrics (2022-2026)
2022 | 2023 | 2024 | 2025 | 2026 | |
---|---|---|---|---|---|
Revenue Metrics | |||||
Revenue | - | - | - | - | - |
Revenue Growth | - | - | - | - | - |
Revenue Multiple | - | - | - | - | - |
Profit Metrics | |||||
Gross Profit | - | - | - | - | - |
Gross Profit Growth | - | - | - | - | - |
Gross Profit Multiple | - | - | - | - | - |
EBITDA Metrics | |||||
EBITDA | - | - | - | - | - |
EBITDA Growth | - | - | - | - | - |
EBITDA Multiple | - | - | - | - | - |
Net Income Metrics | |||||
Net Income | - | - | - | - | - |
Net Income Growth | - | - | - | - | - |
Net Income Multiple | - | - | - | - | - |